PHI-101
PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.
Product Specifications
CAS Number
2127107-15-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
386.44
Molecular Formula
C19H19FN4O2S
Notes
Research use only, not for human use.
Receptor
Chk
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog